Cargando…
Cell-Specific Aptamers as Emerging Therapeutics
Aptamers are short nucleic acids that bind to defined targets with high affinity and specificity. The first aptamers have been selected about two decades ago by an in vitro process named SELEX (systematic evolution of ligands by exponential enrichment). Since then, numerous aptamers with specificiti...
Autores principales: | Meyer, Cindy, Hahn, Ulrich, Rentmeister, Andrea |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE-Hindawi Access to Research
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3166764/ https://www.ncbi.nlm.nih.gov/pubmed/21904667 http://dx.doi.org/10.4061/2011/904750 |
Ejemplares similares
-
Chlorin e6 Conjugated Interleukin-6 Receptor Aptamers Selectively Kill Target Cells Upon Irradiation
por: Kruspe, Sven, et al.
Publicado: (2014) -
Interleukin-6 receptor specific RNA aptamers for cargo delivery into target cells
por: Meyer, Cindy, et al.
Publicado: (2012) -
Charomers—Interleukin-6 Receptor Specific Aptamers for Cellular Internalization and Targeted Drug Delivery
por: Hahn, Ulrich
Publicado: (2017) -
Aptamer Applications in Emerging Viral Diseases
por: Krüger, Arne, et al.
Publicado: (2021) -
Emerging approaches for detection of methylation sites in RNA
por: Ovcharenko, Anna, et al.
Publicado: (2018)